444
Views
23
CrossRef citations to date
0
Altmetric
Research Article

In vitro and in vivo studies on a novel solid dispersion of repaglinide using polyvinylpyrrolidone as the carrier

, , , , , & show all
Pages 1371-1380 | Received 05 May 2011, Accepted 20 Dec 2011, Published online: 02 Feb 2012

References

  • Newa M, Bhandari KH, Li DX, Kwon TH, Kim JA, Yoo BK et al. (2007). Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. Int J Pharm, 343:228–237.
  • Christian L, Jennifer D. (2000). Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm, 50:131–144.
  • Seedher N, Kanojia M. (2009). Co-solvent solubilization of some poorly-soluble antidiabetic drugs. Pharm Dev Technol, 14:185–192.
  • Chiou WL, Riegelman S. (1971). Pharmaceutical applications of solid dispersion systems. J Pharm Sci, 60:1281–1302.
  • Melgardt MV, Dale EW, Jakkie GV, Amol K. (1998). X-Ray powder diffraction determination of the relative amount of crystalline acetaminophen in solid dispersions with polyvinylpyrrolidone. Int J Pharm, 163:219–224.
  • Craig DQ. (2002). The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm, 231:131–144.
  • Huang LF, Tong WQ. (2004). Impact of solid state properties on developability assessment of drug candidates. Adv Drug Deliv Rev, 56:321–334.
  • Sandrien J, Hector NA, Ward A. (2008). Characterization of ternary solid dispersions of Itraconazole in polyethylene glycol 6000/polyvidone-vinylacetate 64 blends. Eur J Pharm Biopharm, 69:1114–1120.
  • Festo D, Norbert B, Lieve N, Jan B, Renaat K. (2000). Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur J Pharm Sci, 10:311–22.
  • Kazunari Y, Toshiomi N, Kazuto O, Atsuo O. (2003). Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int J Pharm, 267:79–91.
  • Xie Y, Xie P, Song X, Tang X, Song H. (2008). Preparation of esomeprazole zinc solid dispersion and study on its pharmacokinetics. Int J Pharm, 360:53–57.
  • Manish I, Shio KS, Bhrameshwar M, Ram CG. (2003). Pharmacokinetics, in-situ absorption and protein binding studies of a new neuroleptic agent centbutindole in rats. Eur J Pharm Sci, 19:105–113.
  • Li H, Zhao X, Ma Y, Zhai G, Li L, Lou H. (2009). Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles. J Control Release, 133:238–244.
  • Paradkar A, Ambike AA, Jadhav BK, Mahadik KR. (2004). Characterization of curcumin-PVP solid dispersion obtained by spray drying. Int J Pharm, 271:281–286.
  • Ahuja N, Katare OP, Singh B. (2007). Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers. Eur J Pharm Biopharm, 65:26–38.
  • Nazik E, Kadria E, Abdallah M, Ahmed E. (2011). Lyophilization monophase solution technique foe preparation of amorphous flutamide dispersions. Drug Dev Ind Pharm, 37:754–764.
  • Van den Mooter G, Augustijns P, Blaton N, Kinget R. (1998). Physicochemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30. Int J Pharm, 164:67–80.
  • Yoshitada K, Yuuji T, Naomi Y, Hiromi N, Koichi T, Hitoshi S. (2009). Enhanced bioavailability of probucol following the administration of solid dispersion systems of probucol-polyvinylpyrrolidone in rabbits. Biol Pharm Bull, 32:1880–1884.
  • Prabhu S, Brocks DR, Betageri GV. (2001). Enhancement of dissolution of ethopropazine using solid dispersions prepared with phospholipid and/or polyethylene glycol. Drug Dev Ind Pharm, 27:413–418.
  • Tantishaiyakul V, Kaewnopparat N, Ingkatawornwong S. (1999). Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. Int J Pharm, 181:143–151.
  • EI-Badry M, Fathy M. (2006). Enhancement of the dissolution and permeation rates of meloxicam by formation of its freeze-dried solid dispersions in polyvinylpyrrolidone K-30. Drug Dev Ind Pharm, 32:141–150.
  • Taylor LS, Zografi G. (1997). Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res, 14:1691–1698.
  • Matsumoto T, Zografi G. (1999). Physical properties of solid molecular dispersions of indomethacin with poly(vinylpyrrolidone) and poly(vinylpyrrolidone-co-vinyl-acetate) in relation to indomethacin crystallization. Pharm Res, 16:1722–1728.
  • Hancock BC, Zografi G. (1997). Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci, 86:1–12.
  • Valizadeh H, Zakeri-Milani P, Barzegar-Jalali M, Mohammadi G, Danesh-Bahreini MA, Adibkia K et al. (2007). Preparation and characterization of solid dispersions of piroxicam with hydrophilic carriers. Drug Dev Ind Pharm, 33:45–56.
  • Nair R, Gonen S, Hoag SW. (2002). Influence of polyethylene glycol and povidone on the polymorphic transformation and solubility of carbamazepine. Int J Pharm, 240:11–22.
  • Ren F, Jing Q, Tang Y, Shen Y, Chen J, Gao F et al. (2006). Characteristics of bicalutamide solid dispersions and improvement of the dissolution. Drug Dev Ind Pharm, 32:967–972.
  • Sekikawa H, Fujiwara J, Naganuma T, Nakano M, Arita T. (1978). Dissolution behaviors and gastrointestinal absorption of phenytoin in phenytoin-polyvinylpyrrolidone coprecipitate. Chem Pharm Bull, 26:3033–3039.
  • Chen S, Zhu J, Ma F, Fang Q, Li Y. (2007). Preparation and characterization of solid dispersions of dipyridamole with a carrier “copolyvidonum Plasdone S-630”. Drug Dev Ind Pharm, 33:888–899.
  • Tantishaiyakul V, Kaewnopparat N, Ingkatavornwong S. (1996). Properties of solid dispersions of piroxicam in polyvinylpyrrolidone K-30. Int J Pharm, 143:59–66.
  • Damian F, Blaton N, Naesens L, Balzarini J, Kinget R, Augustijns P et al. (2000). Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14. Eur J Pharm Sci, 10:311–322.
  • Porubcan LS, Serna CJ, White JL, Hem SL. (1978). Mechanism of adsorption of clindamycin and tetracycline by montmorillonite. J Pharm Sci, 67:1081–1087.
  • Mohanraj P, Jasmina K. (2011). Solid dispersion of prednisolone: solid stste characterization and improvement of dissolution profile. Drug Dev Ind Pharm, 37:373–386.
  • Diaz MTE, Labandeira JJT, Kata M, Jato JLV. (1994). Inclusion complexation of glibenclamide with 2-hydroxypropyl-β-cyclodextrin in solution and in solid state. Eur J Pharm Sci, 1:291–296.
  • Mohammad BJ, Siavoush D. (2007). Kinetic analysis of chlorpropamide dissolution from solid dispersions. Drug Dev Ind Pharm, 33:63–70.
  • Friedrich H, Nada A, Bodmeier R. (2005). Solid state and dissolution rate characterization of co-ground mixtures of nifedipine and hydrophilic carriers. Drug Dev Ind Pharm, 31:719–728.
  • Leuner C, Dressman J. (2000). Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm, 50:47–60.
  • Craig DQM. (2002). The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm, 60:1281–1302.
  • Ford JL. (1986). The current status of solid dispersions. Pharm Acta Helv, 61:69–88.
  • Sekikawa H, Nakano M, Arita T. (1979). Dissolution mechanisms of drug-polyvinylpyrrolidone coprecipitates in aqueous solution. Chem Pharm Bull, 27:1223–1230.
  • Varma MM, Pandi JK. (2005). Dissolution, solubility, XRD, and DSC studies on flurbiprofen-nicotinamide solid dispersions. Drug Dev Ind Pharm, 31:417–423.
  • Valizadeh H, Nokhodchi A, Qarakhani N, Zakeri-Milani P, Azarmi S, Hassanzadeh D et al. (2004). Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit E100. Drug Dev Ind Pharm, 30:303–317.
  • Arias MJ, Myano JR, Gines JM. (1997). Investigation of the tiaamterene-β-cyclodextrin system prepared by co grinding. Int J Pharm, 153:181–189.
  • Rabasco AM, Ginés JM, Fernández-Arévalo M, Holgado MA. (1991). Dissolution rate of diazepam from polyethylene glycol 6000 solid dispersions. Int J Pharm, 67:201–205.
  • Chen J, Qiu L, Hu M, Jin Y, Han J. (2008). Preparation, characterization and in vitro evaluation of solid dispersions containing docetaxel. Drug Dev Ind Pharm, 34:588–594.
  • Nazik E, Kadria E, Abdallah M, Ahmed OE. (2011). Lyophilized flutamide dispersions withs polyols and amino acids: preparation and in vitro evaluation. Drug Dev Ind Pharm, 37:445–455.
  • Cheng J, Wu ZH, Ping QN, Wang B, Lu J. (2010). The absorption characteristics of bifendate solid dispersion in rat intestinal tissue. Drug Dev Ind Pharm, 36:283–291.
  • Milan R. (2009). Theoretical study of molecular structure, pka, lipophilicity, solubility, absorption, and polar surface area of some hypoglycemic agents. J Mol Struct, 897:73–82.
  • Newa M, Bhandari KH, Lee DX, Sung JH, Kim JA, Yoo BK et al. (2008). Enhanced dissolution of ibuprofen using solid dispersion with polyethylene glycol 20000. Drug Dev Ind Pharm, 34:1013–1021.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.